These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4146250)

  • 21. Synergy studies with Pseudomonas aeruginosa resistant to gentamicin and/or carbenicillin.
    Klein RA; Meyer RD
    Chemotherapy; 1978; 24(5):283-9. PubMed ID: 97057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro experiments on the working of combinations of gentamicin and beta-lactam antibiotics against Pseudonomas aeruginosa (author's transl)].
    Ullmann U
    Immun Infekt; 1975 Apr; 3(2):79-85. PubMed ID: 810407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Piperacillin and gentamicin v carbenicillin and gentamicin for treatment of serious gram-negative infections.
    Kohler RB; Foerster LA; Wheat LJ; Williams JM; Reynolds J; Norton J
    Arch Intern Med; 1982 Jul; 142(7):1335-7. PubMed ID: 6212035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of gentamicin and carbenicillin in a rat model against infections with Pseudomonas aeruginosa resistant to gentamicin or gentamicin and carbenicillin.
    Khakoo RA; Kluge RM
    J Antimicrob Chemother; 1979 Jan; 5(1):53-9. PubMed ID: 104952
    [No Abstract]   [Full Text] [Related]  

  • 25. Pseudomonas bacteremia. Evaluation of factors influencing response to therapy.
    Riff LJ
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973; ():Suppl 241:79-8. PubMed ID: 4205064
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapy of neutropenic rats infected with Pseudomonas aeruginosa.
    Lumish RM; Norden CW
    J Infect Dis; 1976 May; 133(5):538-47. PubMed ID: 816976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic activity of gentamicin plus carbenicillin upon Pseudomonas aeruginosa: its relationship with pyocin and antibiotic susceptibility.
    Zemelman R; Mondaca MA; Monge A
    Microbios; 1977; 18(72):79-86. PubMed ID: 417232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absorption, excretion and tissue distribution of sulfocillin administered parenterally in mice, rats, rabbits and dogs.
    Tsuchiya K; Yamazaki T; Kuchimura A; Fugono T
    J Antibiot (Tokyo); 1972 Jun; 25(6):336-42. PubMed ID: 4649863
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of severe pseudomonas infections of the bronchi.
    Pines A; Raafat H; Siddiqui GM; Greenfield JS
    Br Med J; 1970 Mar; 1(5697):663-5. PubMed ID: 4986284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Penicillin resistant mechanisms in Pseudomonas aeruginosa].
    Ichikawa A
    Osaka Daigaku Shigaku Zasshi; 1975 Jun; 20(1):22-44. PubMed ID: 826613
    [No Abstract]   [Full Text] [Related]  

  • 31. Carbenicillin for treatment of Bacteroides fragilis infections: why not penicillin G?
    Maki DG; Kurzynski TA; Agger WA
    J Infect Dis; 1978 Dec; 138(6):859-64. PubMed ID: 253006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetics of mezlocillin and carbenicillin.
    Pancoast SJ; Neu HC
    Clin Pharmacol Ther; 1978 Jul; 24(1):108-16. PubMed ID: 657712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Susceptibility of Pseudomonas aeruginosa to gentamicin, carbenicillin and framycetin].
    Abdou MA
    Arzneimittelforschung; 1973 Jun; 23(6):785-91. PubMed ID: 4199200
    [No Abstract]   [Full Text] [Related]  

  • 34. Experimental pseudomonas osteomyelitis: treatment with sisomicin and carbenicillin.
    Van Wingerden GI; Lolans V; Jackson GG
    J Bone Joint Surg Am; 1974 Oct; 56(7):1452-8. PubMed ID: 4215436
    [No Abstract]   [Full Text] [Related]  

  • 35. Transfer of gentamicin resistance from Pseudomonas aeruginosa strains highly resistant to gentamicin and carbenicillin.
    Knothe H; Krcméry V; Sietzen W; Borst J
    Chemotherapy; 1973; 18(4):229-34. PubMed ID: 4633009
    [No Abstract]   [Full Text] [Related]  

  • 36. In vivo inactivation of gentamicin by carbenicillin and ticarcillin.
    Kradjan WA; Burger R
    Arch Intern Med; 1980 Dec; 140(12):1668-70. PubMed ID: 7458498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of tobramycin and gentamicin against Enterobacteriaceae and gentamicin-resistant, carbenicillin-resistant Pseudomonas aeruginosa.
    Watanakunakorn C; Bannister T
    Curr Ther Res Clin Exp; 1975 May; 17(5):488-96. PubMed ID: 805033
    [No Abstract]   [Full Text] [Related]  

  • 38. Global and effective synergism of amikacin, gentamicin or tobramycin when combined with carbenicillin against Pseudomonas aeruginosa.
    Ximenes J; Hirai CK; Takenaka IM
    J Int Med Res; 1979; 7(5):375-8. PubMed ID: 115732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative in vitro activity of tobramycin, gentamicin, kanamycin, colistin, carbenicillin, and ticarcillin and clinical isolates of Pseudomonas aeruginosa: epidemiological and therapeutic implications.
    Dulong de Rosnay HL; Grimont PA; Dessaut B; Lesgouarres MT
    J Infect Dis; 1976 Aug; 134 Suppl():S50-6. PubMed ID: 823279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transferable resistance to carbenicillin and gentamicin in Pseudomonas aeruginosa.
    van Rensburg AJ
    S Afr Med J; 1974 Jun; 48(28):1185-6. PubMed ID: 4209640
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.